Clinical trials
Adult clinical trials
Below are recruiting adult clinical trials, each written for real people, not researchers. We’re tracking 3,745 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06942117Recruiting
Caffeine's effect on understanding speech in noise
This trial tests whether drinking caffeine helps young adults hear speech better in noisy places. If you have normal hearing, don't smoke, and don't have certain health issues, you might be able to join.
Istanbul, IstanbulAges 18–30 - NCT06942520RecruitingPhase 2
Gene therapy for diabetic macular edema in adults
This trial tests a gene therapy called RGX-314 for people with diabetic macular edema that affects the center of the vision. If you have had previous treatment and still have swelling, this study may be an option.
Reno, NevadaAges 25–89 - NCT07188610RecruitingPhase 2
CAR-T therapy for CD7-positive T-cell leukemia or lymphoma
This trial tests a new treatment called PA3-17, which uses your own immune cells modified to target and kill cancer cells that have a protein called CD7 on them. It is designed for patients with T-cell leukemia or lymphoma that has come back or did not respond to prior treatments.
Hefei, AnhuiAges 18 years+ - NCT07191483RecruitingPhase 2
Study of KYN-5356 for cognitive problems in schizophrenia
This trial tests an investigational drug, KYN-5356, to see if it can improve thinking and memory problems in adults with schizophrenia. You may join if your schizophrenia is stable and you take only one antipsychotic medication.
Little Rock, ArkansasAges 18–55 - NCT07190222RecruitingPhase 3
New medicine for COPD with frequent flare-ups
This study tests a new medicine called Lunsekimig for people with COPD that has frequent flare-ups and high eosinophil levels (a sign of inflammation). It aims to see if it can help control symptoms better than a placebo (a dummy treatment).
Birmingham, AlabamaAges 40–80 - NCT07187440Recruiting
Study of Fabry disease treatment in Chinese children and adults
This study tests an enzyme replacement therapy (agalsidase alfa) for Fabry disease in Chinese children and adults. It's an observational study that follows patients who receive the treatment as part of their regular care.
Hefei, AnhuiAges 7 years+ - NCT07186101RecruitingPhase 2
Testing a new combo therapy for ulcerative colitis
This study tests two drugs together (LY4268989 and mirikizumab) in people with moderate to severe ulcerative colitis. It's for those whose current treatments didn't work well enough.
Scottsdale, ArizonaAges 18–80 - NCT07192614RecruitingPhase 1/Phase 2
Study of AZD6621 for men with advanced prostate cancer
This study tests a new drug called AZD6621 for men with metastatic prostate cancer that no longer responds to standard hormone therapy. The goal is to see how safe it is and whether it can slow down the cancer.
Orlando, FloridaAges 18 years+ - NCT07187401RecruitingPhase 1/Phase 2
Study of a new RNA drug for PNH anemia
This trial tests an experimental RNA drug (ALN-CFB) for people with PNH who still have low red blood cell counts despite taking a C5 inhibitor. The drug aims to block a protein (complement factor B) to improve anemia.
Toronto, OntarioAges 18 years+ - NCT07189806Recruiting
Asthma study tracking symptoms over 5 years
This study follows adults with mild, moderate, or severe asthma to better understand the condition. You'll attend regular check-ups at the clinic to monitor your lung function and symptoms over five years.
LondonAges 18 years+ - NCT06941714Recruiting
How thinking hard affects balance in young adults
This trial looks at how doing mental tasks (cognitive load) affects your balance and stability. You stand and maybe do a simple thinking exercise while your balance is measured, to see if mental effort makes it harder to stay steady.
IslamabadAges 18–30 - NCT06945757Recruiting
Physical activity rehab program for adult cancer patients
This program tests a rehabilitation plan that includes physical activity for people with cancer. It is designed to help you stay active during or after treatment.
Lucerne, Canton of LucerneAges 18–80 - NCT07189091RecruitingPhase 4
Reducing IV fluids in ICU patients
This trial tests if lowering the amount of salt water (sodium chloride) given as maintenance fluids or 'fluid creep' can help critically ill adults in the ICU recover better. It compares two ways of managing daily fluids to see which is safer and more effective.
AntwerpAges 18 years+ - NCT07193095Recruiting
Comparing two brief pain relief programs for chronic pain
This study compares two brief programs (mindfulness skills vs. pain relief education) to see which helps adults with chronic muscle or joint pain feel better. You would attend one or two sessions and complete short questionnaires, all from home.
Tallahassee, FloridaAges 18 years+ - NCT07187193RecruitingPhase 2
Low-dose chemo plus thalidomide for untreated LCH
This trial tests a combination of two drugs, low-dose cytarabine and thalidomide, for adults with Langerhans cell histiocytosis (LCH) that has not been treated before with systemic therapy. The goal is to see if this treatment is safe and effective for people with LCH in multiple body areas or multiple spots in one system.
BeijingAges 18–70 - NCT07189507Recruiting
Older adults: can 26°C indoor temp work?
This study checks if a 26°C indoor temperature is safe and comfortable for older adults with or without high blood pressure or type 2 diabetes. You'll wear different clothing and do daily activities while your body's response is monitored.
Ottawa, OntarioAges 65–85 - NCT07193264Recruiting
Caffeine's effect on blood health in healthy adults
This study looks at how regular or no caffeine intake affects your blood system. It aims to understand if caffeine changes blood cell counts and immune function.
Zurich, Canton of ZurichAges 18 years+ - NCT07185555Recruiting
Low-carb diet for type 1 diabetes and obesity
This study tests a very low-energy ketogenic diet (a special low-carb, low-calorie diet) in adults with type 1 diabetes and obesity who use an automated insulin pump. It aims to see if this diet helps with weight loss and blood sugar control.
Bari, ItalyAges 18–99 - NCT06932432Recruiting
Psychological support study for young adults with chronic pain
This study tests a new approach to psychological support for young adults (ages 18-25) with chronic pain that started in childhood. It uses daily surveys on your smartphone to adjust support based on what you need day to day.
Seattle, WashingtonAges 18–25 - NCT06748443Recruiting
Injury prevention in youth and adult amateur football players
This trial tests a program to prevent injuries in amateur football players aged 10 and older. It's for teams that practice at least twice a week during the season.
LinköpingAges 10 years+ - NCT05300971Recruiting
Heat therapy to lower blood pressure in midlife and older adults
This study tests whether regularly using passive heat can lower your systolic blood pressure (the top number) and improve how your blood vessels work. If you’re eligible, you may be randomly assigned to try the heat therapy as a 6-month program.
Boulder, ColoradoAges 40 years+ - NCT07179848RecruitingPhase 1
Temporal interference brain stimulation safety study in healthy adults
This trial tests a new type of non-invasive brain stimulation that uses a weak electrical field to gently influence brain activity. It is designed for healthy adults to see if the procedure is safe and comfortable, and to gather information that could help develop future treatments for mental health conditions.
TaipeiAges 20–65 - NCT06061094RecruitingPhase 2
Ph+ ALL chemo with targeted pills and transplant
This study tests a combination of chemotherapy, targeted pills (imatinib or ponatinib), and a targeted immunotherapy (blinatumomab) before a stem cell transplant for adults with a specific type of leukemia called Philadelphia chromosome-positive ALL. The goal is to find the best treatment approach.
AachenAges 18–65 - NCT06306196RecruitingPhase 2
Hepatitis E vaccine study in healthy adults, children, and people with HIV
This study tests a hepatitis E vaccine called Hecolin in healthy people (ages 2–45) and in adults (18–45) living with HIV who are on antiviral treatment. It aims to see how well the vaccine works and if it's safe for different groups.
Ga-RankuwaAges 2–45
Hear when a new Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adult?
- Yes. Clin2 currently lists 3,745 recruiting adult studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adult trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adult trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.